Smith Group Asset Management’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-3,940
| Closed | -$207K | – | 342 |
|
|
2020
Q3 | $207K | Buy |
3,940
+820
| +26% | +$43.1K | 0.01% | 168 |
|
|
2020
Q2 | $104K | Sell |
3,120
-30
| -1% | -$1K | 0.01% | 195 |
|
|
2020
Q1 | $86K | Hold |
3,150
| – | – | ﹤0.01% | 222 |
|
|
2019
Q4 | $62K | Buy |
+3,150
| New | +$62K | ﹤0.01% | 269 |
|
|
2019
Q3 | – | Sell |
-2,210
| Closed | -$28K | – | 465 |
|
|
2019
Q2 | $28K | Hold |
2,210
| – | – | ﹤0.01% | 322 |
|
|
2019
Q1 | $32K | Sell |
2,210
-6,800
| -75% | -$98.5K | ﹤0.01% | 340 |
|
|
2018
Q4 | $99K | Buy |
+9,010
| New | +$99K | ﹤0.01% | 284 |
|
|
2015
Q4 | – | Sell |
-55,100
| Closed | -$904K | – | 527 |
|
|
2015
Q3 | $904K | Buy |
+55,100
| New | +$904K | 0.03% | 168 |
|
|
2015
Q1 | – | Sell |
-107,255
| Closed | -$1.29M | – | 464 |
|
|
2014
Q4 | $1.29M | Buy |
+107,255
| New | +$1.29M | 0.05% | 169 |
|
|
2013
Q3 | – | Sell |
-87,370
| Closed | -$1.32M | – | 451 |
|
|
2013
Q2 | $1.32M | Buy |
+87,370
| New | +$1.32M | 0.06% | 174 |
|